Draft Indian Guide Offers Predictable Regulatory Pathway For Nanopharmaceuticals
Executive Summary
While India will continue to apply a case-by-case approach to evaluate nanopharmaceuticals, it has issued draft guidance on the minimum information that sponsors must include in their marketing authorization applications.